Provided by Tiger Trade Technology Pte. Ltd.

Puma Biotechnology

9.69
+0.34003.64%
Pre-market: 9.12-0.5700-5.88%07:03 EDT
Volume:411.94K
Turnover:3.95M
Market Cap:500.20M
PE:19.24
High:9.74
Open:9.40
Low:9.28
Close:9.35
52wk High:9.74
52wk Low:4.30
Shares:51.62M
Float Shares:39.62M
Volume Ratio:1.36
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5036
EPS(LYR):0.6100
ROE:21.97%
ROA:9.81%
PB:3.61
PE(LYR):15.89

Loading ...

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 04

Puma Biotechnology Raises Outlook Despite Q1 Reset

TIPRANKS
·
May 09

Puma Biotechnology Q1 revenue falls on weaker NERLYNX sales; raises 2026 outlook

Reuters
·
May 08

Puma Biotechnology Q1 net loss widens to $3.8 million; revenue falls to $44.8 million

Reuters
·
May 08

BRIEF-Puma Biotechnology Q1 Adjusted EPS USD -0.04

Reuters
·
May 08

Puma Biotechnology Outlook Q2 Total Revenue $52–$55 Mln, Net Income $2–$4 Mln

THOMSON REUTERS
·
May 08

BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
May 07

Puma Biotechnology grants 59,750 inducement RSUs to six new employees

Reuters
·
May 07

Puma Biotechnology Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
May 06

Puma Biotechnology publishes 2025 annual report

Reuters
·
Apr 29

Puma Biotechnology to host conference call on first-quarter results

Reuters
·
Apr 24

Puma Biotechnology announces annual shareholder meeting

Reuters
·
Apr 08

BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Puma Biotechnology grants inducement RSUs covering 31,625 shares to five new employees

Reuters
·
Apr 03

Analysts Are Neutral on Top Healthcare Stocks: Puma Biotechnology (PBYI), Cytek Biosciences (CTKB)

TIPRANKS
·
Feb 27

Puma Biotechnology sees Q1 revenue $38M-$42M, one estimate $49M

TIPRANKS
·
Feb 27

Puma Biotechnology Q4 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate

Benzinga Earnings
·
Feb 27

BRIEF-Puma Biotechnology Q4 Adjusted EPS USD 0.3

Reuters
·
Feb 27

Puma Biotechnology Outlook FY Revenue USD 214-221 Million

THOMSON REUTERS
·
Feb 27

Puma Biotechnology Inc Outlook FY26 Total REV $214–$221 Million

THOMSON REUTERS
·
Feb 27